On Monday, the Indian Council of Medical Research published recommendations for the management of Type 1 Diabetes.
“The guidelines come at a time when the COVID19 pandemic has disproportionately affected people with diabetes population, exposing them to a high risk for severe illness and mortality,” informed ICMR in a statement. The guidelines include a vast umbrella of topics including Epidemiology and Diagnosis and Guide for Differential Diagnosis, Drugs -Insulin and Others, monitoring of metabolic control, etc.
The recommendations were conceptualised and compiled by famous researchers and clinicians, including Dr Nikhil Tandon (HOD of Endocrinology & Metabolism, AIIMS, New Delhi), Dr V Mohan (Director, MDRF, Chennai), and Dr R S Dhaliwal (Head, Division of Non-Communicable Diseases, ICMR Hqrs).
Also Read: Cancer increases risk of developing diabetes: Study
The ICMR has produced guidelines for type 1 diabetes for the first time, having previously exclusively released guidelines for type 2 diabetes.
Type 1 diabetes is a chronic illness in which the pancreas generates little or no insulin on its own.
Type 2 diabetes is the most prevalent, generally affecting adults, and arises when the body develops insulin resistance or fails to produce enough insulin. Type 2 diabetes has increased substantially in countries of all income levels during the last three decades.
Follow Medically Speaking on Instagram
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…